Regulatory PathRegulatory requirements compared

Active substance

Netilmicin

Open in the medicines table

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
NETROMYCINEQ 10MG BASE/ML; EQ 25MG BASE/ML; EQ 100MG BASE/MLinjectable · injectionSCHERINGDiscontinued28 Feb 1983

UK MHRA United Kingdom — marketing authorisations

ProductAuthorisationHolderLegal status
NETTACIN 3 MG/ML EYE DROPS, SOLUTIONPLGB 53941/0015SIFI PHARMACEUTICALS LIMITEDPOM
NETTACIN 3 MG/ML EYE DROPS, SOLUTION IN SINGLE-DOSE CONTAINERPLGB 53941/0016SIFI PHARMACEUTICALS LIMITEDPOM

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
NHS Drug TariffNetilmicin 3mg/ml eye drops 0.3ml unit dose£9.8315 unit dose1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

WHO WHO Model List of Essential Medicines (2025)

  • 21.1. Ophthalmological preparations > Anti-infective agents · core
    Therapeutic equivalent to gentamicin for Other specified conjunctivitis; Therapeutic equivalent to gentamicin for Infectious blepharitis

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), MHRA category lists of UK marketing authorisations (Open Government Licence v3.0), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.